Akcipro-500

Land: Armenia

Språk: engelsk

Kilde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktiv ingrediens:

ciprofloxacin (ciprofloxacin hydrochloride)

Tilgjengelig fra:

Akriti Pharmaceuticals Pvt. Ltd.

INN (International Name):

ciprofloxacin (ciprofloxacin hydrochloride)

Dosering :

500mg

Legemiddelform:

tablets film-coated

Resept typen:

Prescription

Preparatomtale

Summarv
of
product
Characteristics
Name
of the
medicinal
product:
AKCIPRO-SO0
(Ciprofloxacin
Tablets
USp
500
mg)
2.
Qualitative
and
Quantitative
composition:
Batch
Size:
1.00.000
tablets
Sr.
No.
Ingredients
Specifi-
cation
Quantity
/
Tablet
(ms)
o/
Overages
Quantity/
Batch
(Ko)
1.
Ciprofl
oxacin
Hydrochloridi
equivalent
to
Ciprofloxacin
USP
582.21
mg
500
mg
Nil
58.221
2.
Microcrystalline
cellulose
powder
BP
46.68
mg
Nil
4.668
3.
Maize
Starch
(for
paste)
BP
20.42m9
Nil
2.042
i
Purified
Water
BP
q.s
Nil
q.s
5.
Sodium
Starch
Glycolate
BP
13.24
mg
Nit
|
,)z+
o.
Purified
Talc
BP
7.67
mg
Nil
0.662
7.
Magnesium
Stearate
BP
3.78
mg
Nil
0.378
8.
Croscarmellose
sodium
BP
13.24
mg
Nil
1.324
9.
Maize
Starch
(Dried)
BP
9.46
mg
Nil
0.946
t0.
Colloidal
Silicon
Dioxide
BP
3.30
mg
Nil
0.33
11.
Sun
Coat
IH
17.5
mg
Nil
l./)
t2.
Isopropyl
alcohol
BP
q.s
Nil
q.s
13.
Methylene
chloride
BP
q.s
Nil
q.s
Pharmaceutical
Form
Oral
dosage
form
(film
coated
tablet)
ffi
@
4.1
Clinical
Particulars:
Therapeutic
Indications:
ciprofloxacin
is
indicated
for
the
treatment
ofthe
following
infections:
o
Lower
Respiratory
Tract
Infections
o
Urinary
Tract
Infections
.
Skin
and
Soft
Tissue
lnfections
o
Gastro-intestinal
Infections
o
Bone
Infections
r
Gonorrhoea
o
Preventivemaintenanceofpostoperativecomplications.
Posolory
and
method
of
administration:
ciprofloxacin
tablets
shourd
be
swalrowed
whore
with
prenty
of
riquid
and
may
be
taken
with
or
without
meals.
The
dosage-
range
is
250-750
mg
twice
daily.
The
duration
of
treatment
depends
upon
the
severity
of
the
infection,
clini-cal
respons"
*J
;;.'*i;il;;;,"n.Jilr.'"4;ffi,1;,
treatrnent
should
be
continued
for
at
least
3
days
after
the
,igr,
*J,yipr"n'.'"ii'r,"
infection
have
disappeared.
Lower
Respiratory
tract
infections:
250-500
mg
twice
daily.
Usual
duration
of
treatment:
7_14
days.
Urinary
tract
infections:
250-500
mg
twice
daily.
Usual
duration
oftreatrnent:
7_14
days.
Skin
and
soft
tissue
infections:
500
mg
twice
daily.
Usual
duration
oftreatment:
5_10
days.
Gastro-intestinal
Infections:
100
m-S
y